1. Home
  2. SOBR vs SCNI Comparison

SOBR vs SCNI Comparison

Compare SOBR & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SOBR Safe Inc.

SOBR

SOBR Safe Inc.

HOLD

Current Price

$0.84

Market Cap

3.3M

ML Signal

HOLD

SCNI

Scinai Immunotherapeutics Ltd.

HOLD

Current Price

$0.82

Market Cap

2.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOBR
SCNI
Founded
2004
2003
Country
United States
Israel
Employees
N/A
N/A
Industry
Newspapers/Magazines
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3M
2.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SOBR
SCNI
Price
$0.84
$0.82
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
250.4K
60.4K
Earning Date
11-12-2025
03-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.26
Revenue
$364,164.00
$1,147,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$3.03
Revenue Growth
98.07
303.87
52 Week Low
$0.83
$0.61
52 Week High
$14.20
$6.18

Technical Indicators

Market Signals
Indicator
SOBR
SCNI
Relative Strength Index (RSI) 28.32 41.41
Support Level $0.83 $0.75
Resistance Level $0.91 $0.86
Average True Range (ATR) 0.15 0.09
MACD -0.04 -0.02
Stochastic Oscillator 1.53 13.87

Price Performance

Historical Comparison
SOBR
SCNI

About SOBR SOBR Safe Inc.

Sobr Safe Inc provides non-invasive technology to quickly and humanely identify the presence of alcohol in individuals. Its technologies are integrated within robust and scalable data platform, producing statistical and measurable user and business data. It developed the scalable, patent-pending ea4 software platform for non-invasive alcohol detection and identity verification, a solution that has current and potential applications. It generates revenue through various combinations of software products and services which include the sale of cloud-based software solutions, detection and data collection hardware devices, and cloud-based data reporting and analysis services.

About SCNI Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.

Share on Social Networks: